vs
和黄医药（HCM）与PROCORE TECHNOLOGIES, INC.（PCOR）财务数据对比。点击上方公司名可切换其他公司
PROCORE TECHNOLOGIES, INC.的季度营收约是和黄医药的1.3倍（$359.3M vs $270.8M），和黄医药净利率更高（0.7% vs -2.5%，领先3.3%），PROCORE TECHNOLOGIES, INC.同比增速更快（15.7% vs -16.5%）
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
Procore Technologies是2002年成立的美国建筑管理软件即服务（SaaS）企业，总部位于加利福尼亚州卡平特里亚。公司打造的全球平台可连接建筑行业从业者，支持搭建简化工作流，统一展现建筑项目信息，覆盖任务追踪、项目流程管理、日程排期等核心功能。
HCM vs PCOR — 直观对比
营收规模更大
PCOR
是对方的1.3倍
$270.8M
营收增速更快
PCOR
高出32.2%
-16.5%
净利率更高
HCM
高出3.3%
-2.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $270.8M | $359.3M |
| 净利润 | $2.0M | $-9.1M |
| 毛利率 | 37.7% | 80.1% |
| 营业利润率 | -13.2% | 15.5% |
| 净利率 | 0.7% | -2.5% |
| 营收同比 | -16.5% | 15.7% |
| 净利润同比 | -83.6% | 72.4% |
| 每股收益（稀释后） | $0.00 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HCMPCOR
| Q1 26 | — | $359.3M | ||
| Q4 25 | $270.8M | $349.1M | ||
| Q3 25 | — | $338.9M | ||
| Q2 25 | $277.7M | $323.9M | ||
| Q1 25 | $324.5M | $310.6M | ||
| Q4 24 | — | $302.0M | ||
| Q3 24 | — | $295.9M | ||
| Q2 24 | $305.7M | $284.3M |
净利润HCMPCOR
| Q1 26 | — | $-9.1M | ||
| Q4 25 | $2.0M | $-37.6M | ||
| Q3 25 | — | $-9.1M | ||
| Q2 25 | $455.0M | $-21.1M | ||
| Q1 25 | $11.9M | $-33.0M | ||
| Q4 24 | — | $-62.3M | ||
| Q3 24 | — | $-26.4M | ||
| Q2 24 | $25.8M | $-6.3M |
毛利率HCMPCOR
| Q1 26 | — | 80.1% | ||
| Q4 25 | 37.7% | 80.1% | ||
| Q3 25 | — | 79.7% | ||
| Q2 25 | 0.1% | 79.1% | ||
| Q1 25 | 48.0% | 79.1% | ||
| Q4 24 | — | 81.2% | ||
| Q3 24 | — | 81.4% | ||
| Q2 24 | 41.1% | 83.1% |
营业利润率HCMPCOR
| Q1 26 | — | 15.5% | ||
| Q4 25 | -13.2% | -12.3% | ||
| Q3 25 | — | -4.4% | ||
| Q2 25 | -1.3% | -9.3% | ||
| Q1 25 | -5.0% | -11.7% | ||
| Q4 24 | — | -21.9% | ||
| Q3 24 | — | -12.3% | ||
| Q2 24 | -9.0% | -5.2% |
净利率HCMPCOR
| Q1 26 | — | -2.5% | ||
| Q4 25 | 0.7% | -10.8% | ||
| Q3 25 | — | -2.7% | ||
| Q2 25 | 163.8% | -6.5% | ||
| Q1 25 | 3.7% | -10.6% | ||
| Q4 24 | — | -20.6% | ||
| Q3 24 | — | -8.9% | ||
| Q2 24 | 8.4% | -2.2% |
每股收益（稀释后）HCMPCOR
| Q1 26 | — | $-0.06 | ||
| Q4 25 | $0.00 | $-0.25 | ||
| Q3 25 | — | $-0.06 | ||
| Q2 25 | $0.52 | $-0.14 | ||
| Q1 25 | $0.01 | $-0.22 | ||
| Q4 24 | — | $-0.42 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $0.03 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $386.0M |
| 总债务越低越好 | $93.2M | — |
| 股东权益账面价值 | $1.2B | $1.2B |
| 总资产 | $1.8B | $2.1B |
| 负债/权益比越低杠杆越低 | 0.08× | — |
8季度趋势，按日历期对齐
现金及短期投资HCMPCOR
| Q1 26 | — | $386.0M | ||
| Q4 25 | $1.4B | $768.5M | ||
| Q3 25 | — | $684.0M | ||
| Q2 25 | $1.4B | $620.9M | ||
| Q1 25 | $836.1M | $566.7M | ||
| Q4 24 | — | $775.4M | ||
| Q3 24 | — | $756.9M | ||
| Q2 24 | $802.5M | $735.4M |
总债务HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
股东权益HCMPCOR
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.2B | $1.3B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $759.9M | $1.2B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $740.1M | $1.3B |
总资产HCMPCOR
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.8B | $2.2B | ||
| Q3 25 | — | $2.1B | ||
| Q2 25 | $1.8B | $2.0B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $1.3B | $2.0B |
负债/权益比HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.2M | $76.8M |
| 自由现金流经营现金流 - 资本支出 | $3.4M | — |
| 自由现金流率自由现金流/营收 | 1.2% | — |
| 资本支出强度资本支出/营收 | 1.8% | — |
| 现金转化率经营现金流/净利润 | 4.21× | — |
| 过去12个月自由现金流最近4个季度 | $-96.2M | — |
8季度趋势，按日历期对齐
经营现金流HCMPCOR
| Q1 26 | — | $76.8M | ||
| Q4 25 | $8.2M | $114.9M | ||
| Q3 25 | — | $88.5M | ||
| Q2 25 | $-72.9M | $30.8M | ||
| Q1 25 | $40.3M | $66.0M | ||
| Q4 24 | — | $29.1M | ||
| Q3 24 | — | $39.3M | ||
| Q2 24 | $-39.8M | $58.7M |
自由现金流HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $109.2M | ||
| Q3 25 | — | $83.1M | ||
| Q2 25 | $-82.2M | $27.9M | ||
| Q1 25 | $32.5M | $62.0M | ||
| Q4 24 | — | $17.4M | ||
| Q3 24 | — | $35.7M | ||
| Q2 24 | $-49.9M | $56.8M |
自由现金流率HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 31.3% | ||
| Q3 25 | — | 24.5% | ||
| Q2 25 | -29.6% | 8.6% | ||
| Q1 25 | 10.0% | 20.0% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | -16.3% | 20.0% |
资本支出强度HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 1.6% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | 3.3% | 0.9% | ||
| Q1 25 | 2.4% | 1.3% | ||
| Q4 24 | — | 3.9% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | 3.3% | 0.7% |
现金转化率HCMPCOR
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.54× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
